Longboard Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
18.67
|
|
Average Rating
|
4.83
|
|
# Strong Buys
|
5
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.64
|
-0.68
|
-0.04
|
-6.25%
|
|
2022-06-30
|
-0.57
|
-0.67
|
-0.10
|
-17.54%
|
|
2022-03-31
|
-0.55
|
-0.56
|
-0.01
|
-1.82%
|
|
2021-12-31
|
-0.43
|
-0.52
|
-0.09
|
-20.93%
|
|
2021-09-30
|
-0.48
|
-0.38
|
0.10
|
20.83%
|
|
2021-06-30
|
-0.67
|
-0.41
|
0.26
|
38.81%
|
|
2021-03-31
|
-0.94
|
-0.84
|
0.10
|
10.64%
|
|
2020-12-31
|
0.00
|
-0.60
|
-0.60
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.91
|
|
2021-12-31
|
-2.15
|
|
2020-12-31
|
-0.85
|